StockMarketWire.com - Motif Bio has confirmed that the Company will be presenting at the Rodman & Renshaw 19th Annual Global Investment Conference, to be held between the 10th and 12th of September.

In addition, David Huang, MD, PhD, Chief Medical Officer of Motif, will deliver the luncheon keynote address on September 15th at the World Anti-Microbial Resistance Congress in Washington.




At 1:30pm: [LON:MTFB] Motif Bio Plc Ord 1p share price was -0.5p at 27p



Story provided by StockMarketWire.com